Rigel announces proposed public offering of common stock
Rigel Pharmaceuticals announced that it intends to offer and sell up to 15,000,000 shares of its common stock in an underwritten public offering. Rigel expects to grant underwriters a 30-day option to purchase up to an additional 2,250,000 shares of common stock sold in the public offering. April 18, 2018